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The growing demand for rapid diagnosis of tuberculosis 
(TB) has led to the incorporation of nucleic acid ampli-
fication (NAA) tests in case definitions. The objective of 
this study was to evaluate the contribution of a real-time 
polymerase chain reaction (PCR) assay in providing a 
result predictive of a confirmed TB case. Respiratory 
and extra-pulmonary specimens (n = 308) were subjected 
to NAA, culture and smear microscopy. Qualitative PCR 
assessment, translated by an increase in NAA cycles, dis-
regarding template copy number, resulted in an increase 
in confirmed cases, helping to bridge the gap between 
the test’s analytical performance and its actual perfor-
mance in TB diagnosis.
K E Y  W O R D S :  Mycobacterium tuberculosis complex; 
real-time PCR; acid-fast smear microscopy; diagnosis; 
tuberculosis
NUCLEIC ACID AMPLIFICATION (NAA) tests and 
acid-fast bacilli (AFB) smear microscopy are rapid di-
agnostic tests for tuberculosis (TB). The low sensitiv-
ity of smear microscopy1,2 is countered by the excel-
lent analytical performance of commercial NAA tests. 
However, this may not always re ect clinical diag-
nosis.2–4 Although NAA tests have been included in 
TB case de nitions, their use as a stand-alone test is 
not consensual.1,5,6
Real-time polymerase chain reaction (PCR) is sen-
sitive and speci c for detecting Mycobacterium tu-
berculosis complex (MTC) bacilli directly from clini-
cal specimens.2,7 However, the choice of parameters, 
such as the number of ampli cation cycles relative to 
diagnostic criteria, remains open. The objective of 
this study was to evaluate the role of a real-time PCR 
assay in providing a result predictive of a con rmed 
TB case.
MATERIALS AND METHODS
The 308 specimens included in the study comprised 
75 respiratory and 233 extra-pulmonary specimens 
(165 cerebrospinal  uid [CSF] alone). Contaminated 
specimens were processed using N-acetyl-L-cysteine-
sodium hydroxide. Non-contaminated specimens were 
concentrated by centrifuging for 10 min at 13 200× g. 
DNA was extracted from 100 to 500 μl of processed 
specimens. Ziehl-Neelsen smear microscopy and 
Löwenstein-Jensen (LJ) culture (at 37ºC for 60 days) 
were performed for all specimens. AccuProbe (Gen-
Probe, San Diego, CA, USA) was used to con rm MTC 
in NAA-negative, culture-positive specimens. The 
QIAamp® DNA Mini Kit (Qiagen, Izaza, Portugal) 
was used for DNA extraction from heat-inactivated 
specimens.
The artus® M. tuberculosis RG PCR Kit (Qiagen, 
Quilaban, Sintra, Portugal) was used for ampli ca-
tion of a single copy speci c genomic region. Positive, 
negative, extraction and internal controls were used 
with each 45-cycle run on the Rotor-GeneTM 3000 
(Quilaban, Sintra, Portugal). Test results were vali-
dated based on expected results for all controls. 
For quantitative interpretation of NAA, quanti ca-
tion standards were used to generate a standard curve 
and calculate the number of copies of the template 
(directly proportional to the number of MTC bacilli 
present in the sample). Only copy numbers above the 
kit’s analytical detection limit of 0.9 copies/μl were 
considered positive.
Qualitative interpretation of test results was based 
on the visual comparison of readings with those of 
the positive and negative controls, disregarding the 
template copy number or the number of cycles to a 
positive result. 
The NAA test was interpreted blinded to the re-
sults of both smear microscopy and culture.
The test results were classi ed as per the European 
Centre for Disease Prevention and Control and World 
Health Organization TB case de nitions.1 
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